Breaking News: Medtronic to pay $150 million for Medina Medical
HomeAbout UsContact Us1-800-477-6037
Medical Device Daily
Archive Search

User ID

Password

Forgot password

Remember my login



New User ?

Products & Services
Medical Device Daily
Medtech Resources
BioWorld Executive Compensation Report 2014
MDD State of the Industry Report 2013
BioWorld and Medical Device VC Directory 2012
MDD Perspectives
BioWorld Today
Biotech Resources
Perspectives Blog
PMA and 501(k) Approvals


Today's Issue of Medical Device Daily

Wednesday, September 2, 2015

Today's Headlines

Post-Covidien Shopping Spree: Medtronic makes a $150M play for embolization device firm

Medtronic (Dublin) appears to be making good on its promise to invest in and acquire U.S. medical technology following its $42.9 billion purchase of Covidien. The company just acquired Medina Medical (Menlo Park, Calif.), a private firm it already had an ownership stake in, for $150 million plus milestone-based payments.

Continuous monitoring; The Medicare CGM coverage fight

Continuous glucose monitors have been around for a few years, but the Centers for Medicare & Medicaid Services has had little to say about them to date. NHIC, a Medicare administrative contractor that seems to serve as the agency's point for durable medical equipment, has declared that CGMs are not coverable, and the coverage debate is getting noisier every day. (MDD Perspectives)

Reversal in regulatory pathway? Europe's changes to CE mark suddenly make FDA-first approval seem attractive

PARIS — Later this year, the European Union is almost certain to impose a pre-market authorization procedure for novel high-risk implantable medical devices (Medical Device Daily, July 7 and July 8, 2015).


MDD Home   |   About MDD   |   Contact Us   |   Copyright Notices   |   Terms of Use   |   Privacy Statement   |   Free Alerts

Part of Thomson Reuters
thomsonreuters.com | lifesciences.thomsonreuters.com | BioWorld.com | medicaldevicedaily.com